Deep Episode 5: The Hispanic Patient: How Companies Engage with Heart

In this episode of Deep, John Mangano is joined by TelevisaUnivision’s Jorge Daboub (EVP, Client Partnerships — Pharma & Healthcare), an expert in health marketing to the Hispanic community. They dive into the often overlooked Hispanic market in pharma and healthcare, discussing the major gaps in media reach, data representation, and opportunities for growth.

Jorge shares insights on the unique cultural factors that influence Hispanic health behaviors, such as family caregiving and spirituality, highlighting the underrepresentation of Hispanics in health data and clinical trials. He explains how misconceptions about insurance and financial barriers have created blind spots in marketing strategies. Jorge emphasizes the importance of culturally relevant content and the need to build trust with the Hispanic community, particularly through Spanish-language media.

The conversation also touches on the successes seen by brands that have embraced marketing to Hispanics, noting significant returns on investment. Jorge highlights the opportunities available for pharma companies to engage with this growing segment of over 60 million people, and why understanding cultural nuances is essential for better health outcomes and business success.

Share this Post

Related Articles

Despite years of progress in healthcare innovation, too many patients in North America still face barriers to care that stem not from biology, but from geography, income, and systemic inequities. Across North America, millions of people live in “care deserts” with limited or no access to hospitals, pharmacies, or primary care providers. These individuals, many […]

Last week, Cannes Lions 2025 brought together the global advertising industry for a week of high-profile programming, creative celebration, and perhaps most importantly, meaningful connection. Panels offered insight into where marketing is headed, and other insights emerged among leaders between sessions. Here are six key takeaways that reflect the shifting priorities, new challenges, and emerging […]

Last week, a new bill called the “End Prescription Drug Ads Now Act” was introduced in Congress, aiming to ban nearly all direct-to-consumer (DTC) pharmaceutical advertising. While the legislation has sparked headlines, its chances of becoming law are slim due to constitutional concerns and bipartisan disagreement. Still, it reflects growing attention to the pharmaceutical industry […]

Never Miss New Insights

Sign up for the newsletter to ensure our latest whitepapers, research reports, and more are delivered to your inbox.